Project
Development of p53-MDMs Protein-Protein Interaction Inhibitors to Tackle Cancer
| Reference: | COVID/BD/152557/2022 |
|---|---|
| Financing program: | OE |
| Funding organization: | Fundação para a Ciência e a Tecnologia |
| Associated institutions: | Universidade de Lisboa |
Similar Items
Development of p53-MDMs Protein-Protein Interaction Inhibitors to Tackle Cancer
Design, synthesis and biological evaluation of novel p53 activators by targeting p53 protein-protein interactions
Targeting p53 family proteins: on the route to new anticancer agents
Targeting p53 family proteins: on the route to new anticancer agents
Functional, molecular and pharmacological studies of p53 family proteins: from yeast to human cells
Novo: Development of indole-based scaffolds for tackling Cancer and Malaria. Inicial: Development of spirooxindole scaffolds for tackling Cancer and Malaria
Targeting intracellular proteins and protein-protein interactions with site-specific lipobodies: a new approach for intracellular antibodies
TACKLING COLON CANCER STEM CELLS WITH MICRORNAS
Protein interaction with CO Releasing Molecules (CORM)
APPLICATION OF NMR TECHNIQUES TO CHARACTERIZE PROTEIN-PROTEIN INTERACTIONS IN NITROGEN CYCLE AND SULFATE RESPIRATORY CHAIN
Tackling solvation and permeability using computational methods: the role of noncovalent interactions
Rab proteins as novel biomarkers in breast cancer
Dendrimers and Dendrons Ruthenium-based Nanosystems to tackle Challenging Cancers
DRUG DISCOVERY FOR p53 PPI-TARGETS
DRUG DISCOVERY FOR p53 PPI-TARGETS
Identification and characterization of redox regulatory proteins involved in cancer progression
Cellulose bio-nanocomposites as test-strips for protein cancer biomarkers
AMYLOIDETECTORS: Employing amyloid fibrils as biosensors of the interaction of peptides with phospholipids and/or protein domains.
Molecules for Health: choleterol absorption, and expression of its transporter proteins, interactions with drugs
Molecules for Health: choleterol absorption, and expression of its transporter proteins, interactions with drugs
A MINIMAL PROTEIN PHOSPHATASE PTEN - A CANCER THERAPEUTIC AGENT
Physics and Evolution of Knotted Proteins
Toxic protein aggregation in neurodegeneration
Structural Biology of Membrane Proteins
IDENTIFYING TAU-PROTEIN INTERACTORS
Engineered proteins for gas sensing
Protein materials for gas sensing
AdTechP2 - Advanced Separation Technologies for the Protein Purification
The calcium binding S100B protein as a new modulator of the Amyloid protein aggregation
Deciphering carbohydrate: protein interactions in the Human Microbiome - A combined High-throughput and structural approach
Understanding the molecular mechanisms and identifying novel inhibitors of p-gp mediated cancer drug resistance
Inclusive Education and Social Support to Tackle Inequalities in Society
Affinity purification and cell-specific delivery of a p53-encoding plasmid DNA for gene mediated cancer therapy
The physiology and pathophysiology of unfolded protein responses.
Protein targeting and N-terminal acetylation
ROLE OF PLASMODIUM SURFACE PROTEINS IN SEXUAL DEVELOPMENT AND MALARIA TRANSMISSION
Structural biology of membrane proteins: promising candidates for drug development
DATA MINING AND KNOWLEDGE EXTRACTION FROM PROTEIN UNFOLDING SIMULATIONS. A CONTRIBUTION FOR PROTEIN STRUCTURE PREDICTION
Searching for high level rules in protein folding and unfolding: from amyloid diseases to protein structure prediction
NMR investigation of ion-pair modulation of protein structure and dynamics and its relation to protein misfolding diseases
Related publications
Loading publications...